Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | CRHBP | P24387 | 1/20 | 0.41 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30748276 | 0.91 | L3MBTL1 (0.51) | L3MBTL1TDP1KMT2AMAPTALDH1A1 | |
| SCHEMBL29144635 | 0.91 | L3MBTL1 (0.51) | L3MBTL1TDP1KMT2AMAPTALDH1A1 | |
| SCHEMBL784481 | 0.81 | L3MBTL1 (0.54) | L3MBTL1TDP1KMT2AALDH1A1GAA | |
| Hydrazine SCHEMBL3964002 | 0.81 | TDP1 (0.50) | L3MBTL1TDP1KMT2AMAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL6026121 | 0.80 | L3MBTL1 (0.52) | L3MBTL1TDP1KMT2AALDH1A1GAA | |
| SCHEMBL3771280 | 0.80 | TDP1 (0.52) | L3MBTL1TDP1KMT2AMAPTALDH1A1 | |
| SCHEMBL3926762 | 0.80 | TDP1 (0.52) | L3MBTL1TDP1KMT2AMAPTALDH1A1 | |
| SCHEMBL3926414 | 0.80 | TDP1 (0.52) | L3MBTL1TDP1KMT2AMAPTALDH1A1 | |
| SCHEMBL4432039 | 0.80 | TDP1 (0.52) | L3MBTL1TDP1KMT2AMAPTALDH1A1 | |
| SCHEMBL3926418 | 0.79 | TDP1 (0.51) | L3MBTL1TDP1KMT2AMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090318290-A1 | N-(4-PYRIDIN-2-YLBUTYL) BENZAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE SA (FR) | 2009-12-24 | — | — | US | disclosed |
| EP-2041090-A1 | N- (4-PYRIDIN-2-YLBUTYL) BENZAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES | Bayer CropScience SA (FR) | 2009-04-01 | — | — | EP | disclosed |
| WO-2008003745-A1 | N- (4-PYRIDIN-2-YLBUTYL) BENZAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE SA (FR) | 2008-01-10 | — | — | WO | disclosed |
| WO-2008003746-A1 | N-(4-PYRIDIN-2-YLBUTYL) CARBOXAMIDE DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE SA (FR) | 2008-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318290-A1 | N-(4-PYRIDIN-2-YLBUTYL) BENZAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES | CYP1A2, CYP51A1, CYP4B1 | L3MBTL1 3794/4885TDP1 2278/4885KMT2A 1185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.